237 related articles for article (PubMed ID: 32980961)
1. Epidermal growth factor receptor mutations in lung adenocarcinoma: associations between dual-energy spectral CT measurements and histologic results.
Zhang G; Cao Y; Zhang J; Zhao Z; Zhang W; Zhou J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1169-1178. PubMed ID: 32980961
[TBL] [Abstract][Full Text] [Related]
2. Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography.
Li M; Zhang L; Tang W; Jin YJ; Qi LL; Wu N
Eur Radiol; 2019 Jun; 29(6):2989-2997. PubMed ID: 30367185
[TBL] [Abstract][Full Text] [Related]
3. Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.
Li M; Zhang L; Tang W; Duan JC; Jin YJ; Qi LL; Wu N
Cancer Imaging; 2019 Nov; 19(1):77. PubMed ID: 31783917
[TBL] [Abstract][Full Text] [Related]
4. Differentiating invasive thymic epithelial tumors from mediastinal lung cancer using spectral CT parameters.
Deng L; Yang J; Jing M; Zhang B; Han T; Zhang Y; Zhou J
Jpn J Radiol; 2023 Sep; 41(9):973-982. PubMed ID: 37071247
[TBL] [Abstract][Full Text] [Related]
5. The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC.
Lin L; Cheng J; Tang D; Zhang Y; Zhang F; Xu J; Jiang H; Wu H
Sci Rep; 2020 Feb; 10(1):3436. PubMed ID: 32103127
[TBL] [Abstract][Full Text] [Related]
6. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
7. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
[TBL] [Abstract][Full Text] [Related]
8. Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.
Jia TY; Xiong JF; Li XY; Yu W; Xu ZY; Cai XW; Ma JC; Ren YC; Larsson R; Zhang J; Zhao J; Fu XL
Eur Radiol; 2019 Sep; 29(9):4742-4750. PubMed ID: 30778717
[TBL] [Abstract][Full Text] [Related]
9. The value of dual-energy spectral CT in differentiating solitary pulmonary tuberculosis and solitary lung adenocarcinoma.
Zhang G; Li S; Yang K; Shang L; Zhang F; Huang Z; Ren J; Zhang Z; Zhou J; Pu H; Man Q; Kong W
Front Oncol; 2022; 12():1000028. PubMed ID: 36531032
[TBL] [Abstract][Full Text] [Related]
10. Relationship between epidermal growth factor receptor mutations and CT features in patients with lung adenocarcinoma.
Zhang G; Zhao Z; Cao Y; Zhang J; Li S; Deng L; Zhou J
Clin Radiol; 2021 Jun; 76(6):473.e17-473.e24. PubMed ID: 33731263
[TBL] [Abstract][Full Text] [Related]
11. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
12. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
[TBL] [Abstract][Full Text] [Related]
13. Predicting epidermal growth factor receptor mutations in non-small cell lung cancer through dual-layer spectral CT: a prospective study.
Li F; Qi L; Cheng S; Liu J; Chen J; Cui S; Dong S; Wang J
Insights Imaging; 2024 Apr; 15(1):109. PubMed ID: 38679659
[TBL] [Abstract][Full Text] [Related]
14. Dual-layer dual-energy CT for improving differential diagnosis of squamous cell carcinoma from adenocarcinoma at gastroesophageal junction.
Wu M; Sheng M; Li R; Zhang X; Chen X; Liu Y; Liu B; Yu Y; Li X
Front Oncol; 2022; 12():979349. PubMed ID: 36158653
[TBL] [Abstract][Full Text] [Related]
15. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
[TBL] [Abstract][Full Text] [Related]
16. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.
Mei D; Luo Y; Wang Y; Gong J
Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844
[TBL] [Abstract][Full Text] [Related]
17. Computed Tomography Imaging Characteristics: Potential Indicators of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma.
Wang B; Yu N; Han D; Ren Z; Jia Y; Zhang X; He T
J Comput Assist Tomogr; 2021 Nov-Dec 01; 45(6):964-969. PubMed ID: 34581708
[TBL] [Abstract][Full Text] [Related]
18. Quantitative parameters in novel spectral computed tomography: Assessment of Ki-67 expression in patients with gastric adenocarcinoma.
Mao LT; Chen WC; Lu JY; Zhang HL; Ye YS; Zhang Y; Liu B; Deng WW; Liu X
World J Gastroenterol; 2023 Mar; 29(10):1602-1613. PubMed ID: 36970586
[TBL] [Abstract][Full Text] [Related]
19. Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma.
Chen Y; Yang Y; Ma L; Zhu H; Feng T; Jiang S; Wei Y; Wang T; Sun X
Eur J Radiol; 2019 Mar; 112():44-51. PubMed ID: 30777218
[TBL] [Abstract][Full Text] [Related]
20. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
Lee EY; Khong PL; Lee VH; Qian W; Yu X; Wong MP
Clin Nucl Med; 2015 Mar; 40(3):e190-5. PubMed ID: 25608155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
